• Users Online: 1347
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Real-life efficacy and safety of secukinumab: A single-center, retrospective observational study with 52-week follow-up

Neema Shekhar, Radhakrishnan S, Singh Sehdev, Vasudevan Biju, Chatterjee Manas

Year : 2019| Volume: 5| Issue : 1 | Page no: 14-18

   This article has been cited by
1 Eczematous reactions induced by anti-IL17 agents: Report of two cases and possible pathogenic mechanisms
Alba Sánchez-Velázquez, Daniel Falkenhain-López, Alba López-Valle, JoseL Rodríguez Peralto, PabloL Ortiz Romero, Raquel Rivera-Díaz
Indian Journal of Dermatology. 2022; 67(3): 307
[Pubmed]  [Google Scholar] [DOI]
2 Pattern of use of biologics in psoriasis among Indian dermatologists – A cross sectional survey
Shekhar Neema,Disha Dabbas,S. Radhakrishnan,Arun Kumar Yadav
Indian Journal of Dermatology, Venereology and Leprology. 2021; 0: 1
[Pubmed]  [Google Scholar] [DOI]
3 Secukinumab in erythrodermic psoriasis: real world experience of 6 patients successfully treated by injecting at unconventional sites
Maitreyee Panda, Chinmoy Raj, AnilK Panda, Ipsita Debata
Indian Journal of Dermatology. 2021; 66(6): 677
[Pubmed]  [Google Scholar] [DOI]


Read this article